Establishment Labs Holdings Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Establishment Labs Holdings Inc. (ESTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 84.89 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-08
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 84.89K shares, a 65.13% decline year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 22.33K shares, a 21.52% increase year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 4.59K shares, a 87.93% decline year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 57.04K shares, a 122.07% increase year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 327.39K shares, a 44.53% increase from fiscal 2024.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 226.53K shares, a 61.90% increase from fiscal 2023.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 139.92K shares, a 57.28% decline from fiscal 2022.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 327.50K shares, a 57.74% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-03-31 | 84.89K shares 10-Q · filed 2026-05-08 | 107.22K shares derived: sum of 2 quarters · filed 2026-05-08 | 111.81K shares derived: sum of 3 quarters · filed 2026-05-08 | 168.85K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | 22.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 26.91K shares derived: sum of 2 quarters · filed 2026-02-27 | 83.95K shares derived: sum of 3 quarters · filed 2026-02-27 | 327.39K shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 4.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 61.63K shares derived: sum of 2 quarters · filed 2025-11-07 | 305.07K shares 10-Q · filed 2025-11-07 | 323.44K shares derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | 57.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 300.48K shares 10-Q · filed 2025-08-07 | 318.85K shares derived: sum of 3 quarters · filed 2025-08-07 | 356.86K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 243.44K shares 10-Q · filed 2025-05-09 | 261.81K shares derived: sum of 2 quarters · filed 2025-05-09 | 299.82K shares derived: sum of 3 quarters · filed 2025-05-09 | 325.50K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 18.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 56.38K shares derived: sum of 2 quarters · filed 2025-02-28 | 82.06K shares derived: sum of 3 quarters · filed 2025-02-28 | 226.53K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 38.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 63.69K shares derived: sum of 2 quarters · filed 2024-11-12 | 208.15K shares 10-Q · filed 2024-11-12 | 223.98K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 25.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 170.15K shares 10-Q · filed 2024-08-07 | 185.98K shares derived: sum of 3 quarters · filed 2024-08-07 | 211.94K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 144.46K shares 10-Q · filed 2024-05-09 | 160.29K shares derived: sum of 2 quarters · filed 2024-05-09 | 186.25K shares derived: sum of 3 quarters · filed 2024-05-09 | 191.86K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 15.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 41.79K shares derived: sum of 2 quarters · filed 2024-03-04 | 47.40K shares derived: sum of 3 quarters · filed 2024-03-04 | 139.92K shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 25.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 31.57K shares derived: sum of 2 quarters · filed 2023-11-08 | 124.08K shares 10-Q · filed 2023-11-08 | 220.83K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 5.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 98.13K shares 10-Q · filed 2023-08-09 | 194.88K shares derived: sum of 3 quarters · filed 2023-08-09 | 252.46K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 92.52K shares 10-Q · filed 2023-05-10 | 189.27K shares derived: sum of 2 quarters · filed 2023-05-10 | 246.86K shares derived: sum of 3 quarters · filed 2023-05-10 | 408.97K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 96.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 154.34K shares derived: sum of 2 quarters · filed 2023-03-01 | 316.45K shares derived: sum of 3 quarters · filed 2023-03-01 | 327.50K shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 57.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 219.71K shares derived: sum of 2 quarters · filed 2022-11-09 | 230.75K shares 10-Q · filed 2022-11-09 | 339.46K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 162.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 173.16K shares 10-Q · filed 2022-08-09 | 281.87K shares derived: sum of 3 quarters · filed 2022-08-09 | 364.83K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 11.04K shares 10-Q · filed 2022-05-10 | 119.75K shares derived: sum of 2 quarters · filed 2022-05-10 | 202.71K shares derived: sum of 3 quarters · filed 2022-05-10 | 438.81K shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 108.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 191.67K shares derived: sum of 2 quarters · filed 2022-03-01 | 427.76K shares derived: sum of 3 quarters · filed 2022-03-01 | 775.00K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 82.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 319.05K shares derived: sum of 2 quarters · filed 2021-11-09 | 666.29K shares 10-Q · filed 2021-11-09 | 791.31K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 236.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | 583.34K shares 10-Q · filed 2021-07-30 | 708.36K shares derived: sum of 3 quarters · filed 2021-07-30 | 708.36K shares derived: sum of 4 quarters · filed 2021-07-30 |
| 2021-03-31 | 347.24K shares 10-Q · filed 2021-05-06 | 472.26K shares derived: sum of 2 quarters · filed 2021-05-06 | 472.26K shares derived: sum of 3 quarters · filed 2021-05-06 | 768.57K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 125.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 125.02K shares derived: sum of 2 quarters · filed 2021-03-15 | 421.33K shares derived: sum of 3 quarters · filed 2021-03-15 | 492.29K shares 10-K · filed 2021-03-15 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 296.31K shares derived: sum of 2 quarters · filed 2020-11-09 | 367.26K shares 10-Q · filed 2020-11-09 | 438.26K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 296.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 367.26K shares 10-Q · filed 2020-08-07 | 438.26K shares derived: sum of 3 quarters · filed 2020-08-07 | 438.26K shares derived: sum of 4 quarters · filed 2020-08-07 |
| 2020-03-31 | 70.95K shares 10-Q · filed 2020-05-08 | 141.95K shares derived: sum of 2 quarters · filed 2020-05-08 | 141.95K shares derived: sum of 3 quarters · filed 2020-05-08 | 524.95K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | 71.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 71.00K shares derived: sum of 2 quarters · filed 2020-03-16 | 454.00K shares derived: sum of 3 quarters · filed 2020-03-16 | 510.00K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 383.00K shares derived: sum of 2 quarters · filed 2019-11-12 | 439.00K shares 10-Q · filed 2019-11-12 | 471.00K shares derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | 383.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | 439.00K shares 10-Q · filed 2019-08-13 | 471.00K shares derived: sum of 3 quarters · filed 2019-08-13 | 920.00K shares derived: sum of 4 quarters · filed 2019-08-13 |
| 2019-03-31 | 56.00K shares 10-Q · filed 2019-05-15 | 88.00K shares derived: sum of 2 quarters · filed 2019-05-15 | 537.00K shares derived: sum of 3 quarters · filed 2019-05-15 | |
| 2018-12-31 | 32.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | 481.00K shares derived: sum of 2 quarters · filed 2019-03-20 | 810.63K shares 10-K · filed 2019-03-20 | |
| 2018-09-30 | 449.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 778.63K shares 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | 329.63K shares 10-Q · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |